 |
Rifapentine |
|---|---|
| Trade Name | Priftin |
| Orphan Indication | Prophylactic treatment of Mycobacterium avium complex in patients with AIDS and a CD4+ count less than or equal to 75/mm3 |
| USA Market Approval | USA |
| USA Designation Date | 1996-03-12 00:00:00 |
| Sponsor | Hoechst Marion Roussel, Inc.;P.O. Box 9627, Mail Station: H3-M2516;Kansas City, Missouri, 64134 |
